Literature DB >> 14560102

Sepsis and the dendritic cell.

Philip Efron1, Lyle L Moldawer.   

Abstract

Sepsis is a syndrome of significant morbidity and mortality. Unlike the advances made in other diseases processes, improvements in outcome from sepsis, severe sepsis, and septic shock have been modest. Current research has altered our understanding of sepsis pathogenesis such that present models and definitions are still evolving. One relatively novel cell type, the dendritic cell, is the subject of much current investigation in sepsis. Although our present understanding of dendritic cell biology is incomplete, growing evidence supports the importance of this antigen-presenting cell in the normal and maladaptive responses to microbial invasion and tissue injury. A better understanding of this cell's basic biology as well as its potential as a therapeutic target will undoubtedly play increasing roles in the development of new strategies for the treatment of the septic patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14560102     DOI: 10.1097/01.SHK.0000092698.10326.6f

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  27 in total

1.  Decrease of circulating dendritic cells in burn patients.

Authors:  A D'Arpa; A Accardo-Palumbo; G Amato; L D'Amelio; B Napoli; D Pileri; V Cataldo; R Mogavero; C Lombardo; F Conte
Journal:  Ann Burns Fire Disasters       Date:  2007-12-31

Review 2.  Epigenetic regulation of immune cell functions during post-septic immunosuppression.

Authors:  William F Carson; Karen A Cavassani; Yali Dou; Steven L Kunkel
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

3.  Selective effect of burn injury on splenic CD11c(+) dendritic cells and CD8alpha(+)CD4(-)CD11c(+) dendritic cell subsets.

Authors:  Julie Patenaude; Michele D'Elia; Claudine Hamelin; Jacques Bernier
Journal:  Cell Mol Life Sci       Date:  2010-01-20       Impact factor: 9.261

4.  Adoptive transfer of fibrocytes enhances splenic T-cell numbers and survival in septic peritonitis.

Authors:  Jean A Nemzek; Christopher Fry; Bethany B Moore
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

5.  Dendritic cell depletion exacerbates acetaminophen hepatotoxicity.

Authors:  Michael K Connolly; Diego Ayo; Ashim Malhotra; Michael Hackman; Andrea S Bedrosian; Junaid Ibrahim; Napoleon E Cieza-Rubio; Andrew H Nguyen; Justin R Henning; Monica Dorvil-Castro; H Leon Pachter; George Miller
Journal:  Hepatology       Date:  2011-08-08       Impact factor: 17.425

6.  Kinetic and distinct distribution of conventional dendritic cells in the early phase of lipopolysaccharide-induced acute lung injury.

Authors:  Jun Liu; Peng-Shu Zhang; Qing Yu; Ling Liu; Yi Yang; Hai-Bo Qiu
Journal:  Mol Biol Rep       Date:  2012-10-08       Impact factor: 2.316

7.  Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock.

Authors:  Jixin Zhong; Ping Yang; Kenjiro Muta; Robert Dong; Mario Marrero; Feili Gong; Cong-Yi Wang
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

8.  Major hepatectomy induces phenotypic changes in circulating dendritic cells and monocytes.

Authors:  Philip A Efron; Tadashi Matsumoto; Priscilla F McAuliffe; Philip Scumpia; Ricardo Ungaro; Shiro Fujita; Lyle L Moldawer; David Foley; Alan W Hemming
Journal:  J Clin Immunol       Date:  2009-04-22       Impact factor: 8.317

9.  Carbon monoxide down-modulates Toll-like receptor 4/MD2 expression on innate immune cells and reduces endotoxic shock susceptibility.

Authors:  Sebastián A Riquelme; Susan M Bueno; Alexis M Kalergis
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

10.  Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study.

Authors:  Li-Feng Huang; Yong-Ming Yao; Ning Dong; Yan Yu; Li-Xin He; Zhi-Yong Sheng
Journal:  Crit Care       Date:  2010-01-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.